We showed that COMMD3 is one of the many genes that can control tumour aggressiveness and provide evidence that copper chelation in COMMD3 low expressing cells would be a potential strategy to counteract disease progression and metastasis of breast cancer. The gene discussed is COMMD3; the disease is breast carcinoma.